Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Membrane to cortex attachment determines different mechanical phenotypes in LGR5+ and LGR5- colorectal cancer cells

  • Conti, Sefora
  • Venturini, Valeria
  • Cañellas Socias, Adrià
  • Cortina Duran, Carme
  • Abenza, Juan F.
  • Stephan-Otto Attolini, Camille
  • Middendorp Guerra, Emily
  • Xu, Catherine K.
  • Li, Jia Hui
  • Rossetti, Leone
  • Stassi, Giorgio
  • Roca-Cusachs, Pere
  • Diz-Muñoz, Alba
  • Ruprecht, Verena
  • Guck, Jochen
  • Batlle Gómez, Eduard
  • Labernadie, Anna
  • Trepat, Xavier
Colorectal cancer (CRC) tumors are composed of heterogeneous and plastic cell populations, including a pool of cancer stem cells that express LGR5. Whether these distinct cell populations display different mechanical properties, and how these properties might contribute to metastasis is poorly understood. Using CRC patient derived organoids (PDOs), we find that compared to LGR5- cells, LGR5+ cancer stem cells are stiffer, adhere better to the extracellular matrix (ECM), move slower both as single cells and clusters, display higher nuclear YAP, show a higher survival rate in response to mechanical confinement, and form larger transendothelial gaps. These differences are largely explained by the downregulation of the membrane to cortex attachment proteins Ezrin/Radixin/Moesin (ERMs) in the LGR5+ cells. By analyzing single cell RNA-sequencing (scRNA-seq) expression patterns from a patient cohort, we show that this downregulation is a robust signature of colorectal tumors. Our results show that LGR5- cells display a mechanically dynamic phenotype suitable for dissemination from the primary tumor whereas LGR5+ cells display a mechanically stable and resilient phenotype suitable for extravasation and metastatic growth., The work was funded by the Generalitat de Catalunya (AGAUR 2021 SGR 01425 to X.T. and P.R-C., the CERCA Programme, and “ICREA Academia” award to P.R-C., AGAUR SGR-2021-001278 to E.B.); the Spanish Ministry for Science and Innovation MICCINN/FEDER (PID2021-128635NB-I00, MCIN/AEI/ 10.13039/501100011033 and “ERDF-EU A way of making Europe” to X.T., PID2019-110298GB-I00 to P.R-C., Mineco BES-2017-079847 to S.C., PID2020-117011GB-I00 to V.R., PID2020-119917RB-100 to E.B., PID2021-125212OA-I00 to A.L., RYC2020/029736/I to A.L.); the European Research Council (883739 Epifold to X.T., 884623 residualCRC to E.B., 101097753 MechanoSynth to P.R-C.), Fundació la Marató de TV3 (project 201903-30-31-32 to X.T. and E.B. and 201936-30-31 to P.R.-C.); European Commission (H2020-FETPROACT-01-2016-731957 to P.R-C. and X.T.); La Caixa Foundation (LCF/PR/HR20/52400004 and ID 100010434 under the agreement LCF/PR/HR20/52400004 to P.R-C. and X.T., LCF/BQ/PR18/11640001 to A.L.); The European Molecular Biology Laboratory (to A.D-M.); The EMBL Interdisciplinary Postdocs (EIPOD) fellowship under Marie Sklodowska-Curie Actions COFUND and Joachim Herz Foundation Add-on fellowship (to J.H.L); European Union’s Horizon EIC-ESMEA Pathfinder program under grant agreement (101046620 to V.R.); and The Peter and Traudl Engelhorn postdoctoral fellowship to C.K.X; European Union–- NextGenerationEU through the Italian Ministry of University and Research under PNRR–- M4C2-I1.3 Project PE_00000019““HEAL ITALIA (G.S.). IBEC, CRG and IRB are recipients of a Severo Ochoa Award of Excellence from the MINECO.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing

  • Perucca, Alice
  • Gómez-Llonín, Andrea
  • Rivas, Elisa
  • Linares, Jenniffer
  • Garrido, Marta
  • Sallent-Aragay, Anna
  • Recort-Bascuas, Alba
  • Comerma Blesa, Laura, 1983-
  • Rovira, Ana
  • Albanell Mestres, Joan
  • Calon, Alexandre
  • Labernadie, Anna
Immunotherapies are beneficial for a considerable proportion of cancer patients, but ineffective in others. In vitro modelling of the complex interactions between cancer cells and their microenvironment could provide a path to understanding immune therapy sensitivity and resistance. Here we develop MIRO, a fully humanised in vitro platform to model the spatial organisation of the tumour/stroma interface and its interaction with immune cells. We find that stromal barriers are associated with immune exclusion and protect cancer cells from antibody-dependent cellular cytotoxicity, elicited by targeted therapy. We demonstrate that IL2-driven immunomodulation increases immune cell velocity and spreading to overcome stromal immunosuppression and restores anti-cancer response in refractory tumours. Collectively, our study underscores the translational value of MIRO as a powerful tool for exploring how the spatial organisation of the tumour microenvironment shapes the immune landscape and influences the responses to immunomodulating therapies., We thank S. Usieto, S. Menendez Romero, D. Zafra Puerta, A. Menendez, D. Izquierdo Garcia, C. Rols, J. Durand for their technical assistance. A.L. acknowledges funding from “La Caixa” Banking Foundation (LCF/BQ/PR18/11640001) and from the Spanish Ministry for Science and Innovation MICIU/AEI /10.13039/501100011033 and “ERDF-EU A way of making Europe”, (PID2021-128635NB-I00), and “ESF Investing in your future”, (RYC2020/029736/I). This work was also supported by grants from Instituto de Salud Carlos III (ISCIII) co-funded by the European Union (EU) (PI17/00211, CP16/00151, PI20/00011; Spanish Ministry of Economy and Competitiveness) to A.C. A.C. is the recipient of Miguel Servet research contracts from Instituto de Salud Carlos III co-funded by the European Union (MS16/00151, CPII21/00012). J.A. acknowledges funding from the Generalitat de Catalunya (AGAUR 2021 SGR 00776), the CIBERONC (CB16/12/00241), and the ISCIII co-funded by the EU (PI21/00002). This work was also supported by the Plan de Recuperación, Transformación y Resiliencia (CNS2023-145267) co-funded by the European Union to A.C. P.R.-C. acknowledges funding from the Spanish Ministry of Science and Innovation (PID2022-142672NB-I00), the European Research Council (AdG 101097753), the Generalitat de Catalunya (2017-SGR-1602), and the prize ‘ICREA Academia’ for excellence in research. X.T. acknowledges funding from the Generalitat de Catalunya (AGAUR SGR-2017-01602), the CERCA Programme, the Spanish Ministry for Science and Innovation MICCINN/FEDER (PID2021-128635NB-I00 MCIN/AEI/ 10.13039/501100011033 and “ERDF-EU A way of making Europe”), European Research Council (Adv-883739), Fundació la Marató de TV3 (project 201903-30-31-32), European Commission (H2020-FETPROACT-01-2016-731957), La Caixa Foundation (LCF/PR/HR20/52400004 and ID 100010434 under the agreement LCF/PR/HR20/52400004); IBEC and IRB are recipient of a Severo Ochoa Award of Excellence from the MINECO. This work was also supported by Grant PT20/00023, funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union, and the “Xarxa de Bancs de tumors” sponsored by Pla Director d’Oncologia de Catalunya (XBTC).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Stiffness-dependent active wetting enables optimal collective cell durotaxis

  • Esteve Pallarès, Macià
  • Pi-Jaumà, Irina
  • Corina Fortunato, Isabela
  • Grazú, Valeria
  • Gómez-González, Manuel
  • Roca-Cusachs, Pere
  • Fuente, Jesús M. de la
  • Alert, Ricard
  • Sunyer, Raimon
  • Casademunt, Jaume
  • Trepat, Xavier
The directed migration of cellular clusters enables morphogenesis, wound healing and collective cancer invasion. Gradients of substrate stiffness direct the migration of cellular clusters in a process called collective durotaxis, but the underlying mechanisms remain unclear. Here we unveil a connection between collective durotaxis and the wetting properties of cellular clusters. We show that clusters of cancer cells dewet soft substrates and wet stiff ones. At intermediate stiffness—at the crossover from low to high wettability—clusters on uniform-stiffness substrates become maximally motile, and clusters on stiffness gradients exhibit optimal durotaxis. Durotactic velocity increases with cluster size, stiffness gradient and actomyosin activity. We demonstrate this behaviour on substrates coated with the cell–cell adhesion protein E-cadherin and then establish its generality on substrates coated with extracellular matrix. We develop an active wetting model that explains collective durotaxis in terms of a balance between in-plane active traction and tissue contractility and out-of-plane surface tension. Finally, we show that the distribution of cluster displacements has a heavy tail, with infrequent but large cellular hops that contribute to durotactic migration. Our study demonstrates a physical mechanism of collective durotaxis, through both cell–cell and cell–substrate adhesion ligands, based on the wetting properties of active droplets., This paper was funded by the Generalitat de Catalunya (AGAUR SGR-2017-01602 to X.T., AGAUR SGR-2017-1061 to J.C., the CERCA Programme and ‘ICREA Academia’ awards to P.R.-C. and J.C.); the Spanish Ministry for Science and Innovation MICCINN/FEDER (PGC2018-099645-B-I00 to X.T., PID2019-110298GB-I00 to P.R.-C., PID2019-108842GB-C21 to J.C., RTI2018-101256-J-I00 and RYC2019-026721-I to R.S., FPU19/05492 to I.P.-J., FPU15/06516 to M.-E.P.); Fondo Social de la DGA (grupos DGA) to V.G. and J.M.d.l.F.; European Research Council (Adv-883739 to X.T.); Fundació la Marató de TV3 (project 201903-30-31-32 to X.T.); the European Commission (H2020-FETPROACT-01-2016-731957 to P.R.-C. and X.T.); the European Union’s Horizon 2020 research and innovation programme (under the Marie Skłodowska-Curie grant agreement no. 797621 to M.G.-G.); the European Foundation for the Study of Chronic Liver Failure (EF-Clif); and the La Caixa Foundation (LCF/PR/HR20/52400004 to P.R.-C. and X.T.). IBEC is the recipient of a Severo Ochoa Award of Excellence from MINECO. R.S. is a Serra Húnter fellow., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The laminin–keratin link shields the nucleus from mechanical deformation and signalling

  • Kechagia, Zanetta
  • Sáez, Pablo
  • Gómez-González, Manuel
  • Canales, Brenda
  • Viswanadha, Srivatsava
  • Zamarbide, Martín
  • Andreu, Ion
  • Koorman, Thijs
  • Beedle, Amy E. M.
  • Elosegui-Artola, Alberto
  • Derksen, Patrick W. B.
  • Trepat, Xavier
  • Arroyo, Marino
  • Roca-Cusachs, Pere
The mechanical properties of the extracellular matrix dictate tissue behaviour. In epithelial tissues, laminin is a very abundant extracellular matrix component and a key supporting element. Here we show that laminin hinders the mechanoresponses of breast epithelial cells by shielding the nucleus from mechanical deformation. Coating substrates with laminin-111—unlike fibronectin or collagen I—impairs cell response to substrate rigidity and YAP nuclear localization. Blocking the laminin-specific integrin β4 increases nuclear YAP ratios in a rigidity-dependent manner without affecting the cell forces or focal adhesions. By combining mechanical perturbations and mathematical modelling, we show that β4 integrins establish a mechanical linkage between the substrate and keratin cytoskeleton, which stiffens the network and shields the nucleus from actomyosin-mediated mechanical deformation. In turn, this affects the nuclear YAP mechanoresponses, chromatin methylation and cell invasion in three dimensions. Our results demonstrate a mechanism by which tissues can regulate their sensitivity to mechanical signals., We acknowledge funding from the Spanish Ministry of Science and Innovation (PID2021-128635NB-I00 MCIN/AEI/10.13039/501100011033 and ‘ERDF-EU A way of making Europe’ to X.T., PID2019-110949GB-I00 to M.A. and PID2019-110298GB-I00 to P.R.-C.), the European Commission (H2020-FETPROACT-01-2016-731957), the European Research Council (Adv-883739 to X.T.; CoG-681434 to M.A.; StG- 851055 to A.E.-A.), the Generalitat de Catalunya (2017-SGR-1602 to X.T. and P.R.-C.; 2017-SGR-1278 to M.A. and P.S.) and European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no. 797621 to M.G.-G. The prize ‘ICREA Academia’ for excellence in research to M.A. and P.R.-C., Fundació la Marató de TV3 (201936-30-31 and 201903-30-31-32), and ‘la Caixa’ Foundation (LCF/PR/HR20/52400004 and ID 100010434 under agreement LCF/PR/HR20/52400004). IBEC and CIMNE are recipients of a Severo Ochoa Award of Excellence from MINCIN. A.E.M.B. was supported by a Sir Henry Wellcome Fellowship (210887/Z/18/Z). A.E.-A. receives funding from the Francis Crick Institute, which receives its core funding from the Cancer Research UK (CC2214), the UK Medical Research Council (CC2214) and the Wellcome Trust (CC2214)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing

  • Perucca, Alice
  • Gómez-Llonín, Andrea
  • Rivas, Elisa
  • Linares, Jenniffer
  • Garrido, Marta
  • Sallent-Aragay, Anna
  • Recort-Bascuas, Alba
  • Comerma Blesa, Laura, 1983-
  • Rovira, Ana
  • Albanell Mestres, Joan
  • Calon, Alexandre
  • Labernadie, Anna
Immunotherapies are beneficial for a considerable proportion of cancer patients, but ineffective in others. In vitro modelling of the complex interactions between cancer cells and their microenvironment could provide a path to understanding immune therapy sensitivity and resistance. Here we develop MIRO, a fully humanised in vitro platform to model the spatial organisation of the tumour/stroma interface and its interaction with immune cells. We find that stromal barriers are associated with immune exclusion and protect cancer cells from antibody-dependent cellular cytotoxicity, elicited by targeted therapy. We demonstrate that IL2-driven immunomodulation increases immune cell velocity and spreading to overcome stromal immunosuppression and restores anti-cancer response in refractory tumours. Collectively, our study underscores the translational value of MIRO as a powerful tool for exploring how the spatial organisation of the tumour microenvironment shapes the immune landscape and influences the responses to immunomodulating therapies., We thank S. Usieto, S. Menendez Romero, D. Zafra Puerta, A. Menendez, D. Izquierdo Garcia, C. Rols, J. Durand for their technical assistance. A.L. acknowledges funding from “La Caixa” Banking Foundation (LCF/BQ/PR18/11640001) and from the Spanish Ministry for Science and Innovation MICIU/AEI /10.13039/501100011033 and “ERDF-EU A way of making Europe”, (PID2021-128635NB-I00), and “ESF Investing in your future”, (RYC2020/029736/I). This work was also supported by grants from Instituto de Salud Carlos III (ISCIII) co-funded by the European Union (EU) (PI17/00211, CP16/00151, PI20/00011; Spanish Ministry of Economy and Competitiveness) to A.C. A.C. is the recipient of Miguel Servet research contracts from Instituto de Salud Carlos III co-funded by the European Union (MS16/00151, CPII21/00012). J.A. acknowledges funding from the Generalitat de Catalunya (AGAUR 2021 SGR 00776), the CIBERONC (CB16/12/00241), and the ISCIII co-funded by the EU (PI21/00002). This work was also supported by the Plan de Recuperación, Transformación y Resiliencia (CNS2023-145267) co-funded by the European Union to A.C. P.R.-C. acknowledges funding from the Spanish Ministry of Science and Innovation (PID2022-142672NB-I00), the European Research Council (AdG 101097753), the Generalitat de Catalunya (2017-SGR-1602), and the prize ‘ICREA Academia’ for excellence in research. X.T. acknowledges funding from the Generalitat de Catalunya (AGAUR SGR-2017-01602), the CERCA Programme, the Spanish Ministry for Science and Innovation MICCINN/FEDER (PID2021-128635NB-I00 MCIN/AEI/ 10.13039/501100011033 and “ERDF-EU A way of making Europe”), European Research Council (Adv-883739), Fundació la Marató de TV3 (project 201903-30-31-32), European Commission (H2020-FETPROACT-01-2016-731957), La Caixa Foundation (LCF/PR/HR20/52400004 and ID 100010434 under the agreement LCF/PR/HR20/52400004); IBEC and IRB are recipient of a Severo Ochoa Award of Excellence from the MINECO. This work was also supported by Grant PT20/00023, funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union, and the “Xarxa de Bancs de tumors” sponsored by Pla Director d’Oncologia de Catalunya (XBTC).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Membrane to cortex attachment determines different mechanical phenotypes in LGR5+ and LGR5- colorectal cancer cells

  • Conti, Sefora
  • Venturini, Valeria
  • Cañellas Socias, Adrià
  • Cortina Duran, Carme
  • Abenza, Juan F.
  • Stephan-Otto Attolini, Camille
  • Middendorp Guerra, Emily
  • Xu, Catherine K.
  • Li, Jia Hui
  • Rossetti, Leone
  • Stassi, Giorgio
  • Roca-Cusachs, Pere
  • Diz-Muñoz, Alba
  • Ruprecht, Verena
  • Guck, Jochen
  • Batlle Gómez, Eduard
  • Labernadie, Anna
  • Trepat, Xavier
Colorectal cancer (CRC) tumors are composed of heterogeneous and plastic cell populations, including a pool of cancer stem cells that express LGR5. Whether these distinct cell populations display different mechanical properties, and how these properties might contribute to metastasis is poorly understood. Using CRC patient derived organoids (PDOs), we find that compared to LGR5- cells, LGR5+ cancer stem cells are stiffer, adhere better to the extracellular matrix (ECM), move slower both as single cells and clusters, display higher nuclear YAP, show a higher survival rate in response to mechanical confinement, and form larger transendothelial gaps. These differences are largely explained by the downregulation of the membrane to cortex attachment proteins Ezrin/Radixin/Moesin (ERMs) in the LGR5+ cells. By analyzing single cell RNA-sequencing (scRNA-seq) expression patterns from a patient cohort, we show that this downregulation is a robust signature of colorectal tumors. Our results show that LGR5- cells display a mechanically dynamic phenotype suitable for dissemination from the primary tumor whereas LGR5+ cells display a mechanically stable and resilient phenotype suitable for extravasation and metastatic growth., The work was funded by the Generalitat de Catalunya (AGAUR 2021 SGR 01425 to X.T. and P.R-C., the CERCA Programme, and “ICREA Academia” award to P.R-C., AGAUR SGR-2021-001278 to E.B.); the Spanish Ministry for Science and Innovation MICCINN/FEDER (PID2021-128635NB-I00, MCIN/AEI/ 10.13039/501100011033 and “ERDF-EU A way of making Europe” to X.T., PID2019-110298GB-I00 to P.R-C., Mineco BES-2017-079847 to S.C., PID2020-117011GB-I00 to V.R., PID2020-119917RB-100 to E.B., PID2021-125212OA-I00 to A.L., RYC2020/029736/I to A.L.); the European Research Council (883739 Epifold to X.T., 884623 residualCRC to E.B., 101097753 MechanoSynth to P.R-C.), Fundació la Marató de TV3 (project 201903-30-31-32 to X.T. and E.B. and 201936-30-31 to P.R.-C.); European Commission (H2020-FETPROACT-01-2016-731957 to P.R-C. and X.T.); La Caixa Foundation (LCF/PR/HR20/52400004 and ID 100010434 under the agreement LCF/PR/HR20/52400004 to P.R-C. and X.T., LCF/BQ/PR18/11640001 to A.L.); The European Molecular Biology Laboratory (to A.D-M.); The EMBL Interdisciplinary Postdocs (EIPOD) fellowship under Marie Sklodowska-Curie Actions COFUND and Joachim Herz Foundation Add-on fellowship (to J.H.L); European Union’s Horizon EIC-ESMEA Pathfinder program under grant agreement (101046620 to V.R.); and The Peter and Traudl Engelhorn postdoctoral fellowship to C.K.X; European Union–- NextGenerationEU through the Italian Ministry of University and Research under PNRR–- M4C2-I1.3 Project PE_00000019““HEAL ITALIA (G.S.). IBEC, CRG and IRB are recipients of a Severo Ochoa Award of Excellence from the MINECO.